SPI and Remifentanil in Skull Pin Fixation

Launched by KAOHSIUNG MEDICAL UNIVERSITY CHUNG-HO MEMORIAL HOSPITAL · Mar 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a specific pain management method during a type of brain surgery called skull pin fixation. It focuses on using a combination of medications (remifentanil and propofol) to ensure patients are comfortable and free from pain while maintaining stable blood pressure and heart rate. The trial will involve 40 patients aged 20 to 80 who are scheduled for this surgery and have a low risk for anesthesia complications. Participants will receive careful monitoring throughout the procedure to adjust the medication as needed, ensuring they remain at the right level of anesthesia.

To be eligible for this trial, patients must be between 20 and 80 years old, have a low anesthesia risk (classified as ASA I to III), and be scheduled for the surgery. However, those with higher anesthesia risk or allergies to the study medications will not be eligible. Participants can expect to have their heart rate and blood pressure monitored closely during the surgery, with adjustments made to the medication based on their comfort level. This study aims to improve pain management techniques during such procedures, potentially leading to better outcomes for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Must be at least 20 years old and less than 80 years old
• • 2. With anesthesia risk grade below grade three (including grade three) (ASA I\~III).
• • 3. Patients who are expected to undergo intracranial surgery for skull pin fixation
• Exclusion Criteria:
• • 1. Those with anesthesia risk classification ASA class IV or higher
• • 2. Those who are allergic to opioid analgesics or propofol drugs
• • 3. Emergency patients